Haemonetics Corporation Free Cash Flow 2009–2026
Haemonetics Corporation reported $260.44M of free cash flow for fiscal 2026. That was 82.8% higher than fiscal 2025. Compared with fiscal 2021, the change was +262.9%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2026 | $260.44M | +82.8% |
| FY 2025 | $142.45M | -0.8% |
| FY 2024 | $143.63M | +75.7% |
| FY 2023 | $81.73M | +7.9% |
| FY 2022 | $75.75M | +5.6% |
| FY 2021 | $71.77M | -34.4% |
| FY 2020 | $109.46M | +171.5% |
| FY 2019 | $40.32M | -72.3% |
| FY 2018 | $145.55M | +74.1% |
| FY 2017 | $83.60M | +329.6% |
| FY 2016 | $19.46M | +292.5% |
| FY 2015 | $4.96M | -92.5% |
| FY 2014 | $65.88M | +187.8% |
| FY 2013 | $22.89M | -63.2% |
| FY 2012 | $62.12M | -19.1% |
| FY 2011 | $76.79M | +3.3% |
| FY 2010 | $74.36M | +24.0% |
| FY 2009 | $59.98M | — |
Source: Haemonetics Corporation SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open HAE 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Haemonetics Corporation reported $260.44M of free cash flow for fiscal 2026. That was 82.8% higher than fiscal 2025. Compared with fiscal 2021, the change was +262.9%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Haemonetics Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHaemonetics Corporation — frequently asked questions
What is Haemonetics Corporation's free cash flow?
Haemonetics Corporation (HAE) reported free cash flow of $260.44M for fiscal year 2026, per its SEC filings.
How has Haemonetics Corporation's free cash flow changed over time?
Between fiscal 2009 and 2026, HAE's free cash flow grew at roughly 9.0% per year (compound annual rate), from $59.98M to $260.44M.
Where does this data come from?
Figures are computed from Haemonetics Corporation's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.